360 related articles for article (PubMed ID: 27102765)
1. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
[TBL] [Abstract][Full Text] [Related]
3. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
[TBL] [Abstract][Full Text] [Related]
4. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
Lourdudoss C; Ajeganova S; Frostegård J
Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
[TBL] [Abstract][Full Text] [Related]
5. Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.
Su J; Frostegård AG; Hua X; Gustafsson T; Jogestrand T; Hafström I; Frostegård J
J Rheumatol; 2013 Nov; 40(11):1856-64. PubMed ID: 24037548
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.
Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J
PLoS One; 2014; 9(12):e111764. PubMed ID: 25473948
[TBL] [Abstract][Full Text] [Related]
7. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
[TBL] [Abstract][Full Text] [Related]
8. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus.
Grönwall C; Reynolds H; Kim JK; Buyon J; Goldberg JD; Clancy RM; Silverman GJ
Clin Immunol; 2014 Jul; 153(1):1-7. PubMed ID: 24704464
[TBL] [Abstract][Full Text] [Related]
9. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J
Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913
[TBL] [Abstract][Full Text] [Related]
10. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
[TBL] [Abstract][Full Text] [Related]
11. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.
Grönwall C; Clancy RM; Getu L; Lloyd KA; Siegel DL; Reed JH; Buyon JP; Silverman GJ
J Autoimmun; 2016 Sep; 73():30-41. PubMed ID: 27289167
[TBL] [Abstract][Full Text] [Related]
12. Natural antibodies against phosphorylcholine in cardiovascular disease.
de Faire U; Frostegård J
Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
[TBL] [Abstract][Full Text] [Related]
13. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
[TBL] [Abstract][Full Text] [Related]
14. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
[TBL] [Abstract][Full Text] [Related]
18. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
19. Potential natural immunization against atherosclerosis in hibernating bears.
Samal SK; Fröbert O; Kindberg J; Stenvinkel P; Frostegård J
Sci Rep; 2021 Jun; 11(1):12120. PubMed ID: 34108551
[TBL] [Abstract][Full Text] [Related]
20. Natural antibodies against phosphorylcholine as potential protective factors in SLE.
Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J
Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
